Delivery Order SPE2DR25D6044-SPE2DR26FYA3P
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Duloxetine HCl DR 30 mg capsules (1,000 count) under a firm fixed-price contract valued at $1,800.00. This award, issued on December 4, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle designated SPE2DX and running through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Duloxetine HCL (delayed-release) 30 mg capsules in a quantity of 1,000 units, valued at $1,711.00. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by December 10, 2025, with performance taking place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 units of Duloxetine HCL DR 30 mg capsules under a firm fixed-price contract valued at $1,207.55. The order was competitively awarded without set-aside designation and is scheduled for completion by November 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Duloxetine HCL DR 20 mg capsules (1,000 count) with a ceiling value of $1,016.71. This firm fixed-price delivery order, which is not set-aside, represents a competitively awarded pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $39,410.23 to AmerisourceBergen Drug Corp for the supply of 1,000 units of Duloxetine HCL DR 30 mg capsules. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 25, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed and delivered from the vendor's facility in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency valued at $2,393.10 for 1,000 capsules of Duloxetine HCL DR 20 mg. Awarded on December 1, 2025, with a completion date of December 2, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract is performed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a Delivery Order contract to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Duloxetine HCL DR 30 mg capsules (1,000 units) valued at $6,441.21 with a firm fixed price structure. This delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of December 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Duloxetine is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count unit) with a ceiling value of $1,487.88. This non-set-aside, firm fixed-price delivery order is scheduled for completion by October 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,919.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of 1,000 capsules of Duloxetine HCL DR 20 mg. This non-set-aside contract, which is due for completion by August 13, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,470.07 to AmerisourceBergen Drug Corp for the supply of 1,000 units of Duloxetine HCl DR 20 mg capsules. This order, issued on October 30, 2025, with an ultimate completion date of October 31, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken,...
- SPE2DR25D6044Indefinite Delivery Contract
- SPE2DR25D6044-SPE2DR26FYA3PDelivery Order
The Defense Logistics Agency awarded a $4,657.95 delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Duloxetine HCL DR 30 mg on December 5, 2025, with an ultimate completion date of December 8, 2025. This contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Duloxetine is a widely prescribed serotonin-norepinephrine reuptake inhibitor (SNRI) used to treat depression, anxiety, and chronic pain conditions, making it a critical pharmaceutical commodity for military and veteran healthcare systems. AmerisourceBergen's role as a prime pharmaceutical vendor through the DLA Troop Support Medical contract enables the company to supply a comprehensive range of generic and brand-name medications to support Defense Health Agency operations and other federal healthcare systems. The successful completion of this delivery order reflects AmerisourceBergen's established capability to meet federal procurement requirements for essential pharmaceutical products on an expedited timeline.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 12/4/25 |